News

Video

Dr Jennifer Gass Provides an Overview of FCS' Next-Generation Sequencing Laboratory

Author(s):

Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation sequencing (NGS) testing in oncology care.

The state-of-the-art Florida Cancer Specialists & Research Institute (FCS) laboratory provides next-generation sequencing (NGS) testing, which helps oncologists identify genetic mutations in hundreds of different genes, all at once.

Transcript

How are things going and who is the team at the team at the new NGS laboratory that opened about a year ago at FCS?

Our pathology lab is made up of 8 different pathologist, 2 laboratory geneticist, and multiple departments. My department is the molecular department, and we are the ones that run the next generation sequencing (NGS). And within that department, we have 10 technologists and 2 variants scientists, as well as a molecular manager to support our NGS testing.

Everything is going well! we launched our first NGS test in July of 2021 and now we have brought on another test, so we support both solid tumor and hematological malignancies. And we look forward to bringing on more technologies with NGS as well as more molecular technologies.

Related Videos
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Emma Achola-Kothari
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Dr Margrit Wiesendanger
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo